These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The influence of the technique of surfactant administration (LISA vs INSURE) on the outcomes of respiratory distress syndrome treatment in preterm infants. Kaniewska U; Gulczyńska E Dev Period Med; 2019; 23(3):163-171. PubMed ID: 31654994 [TBL] [Abstract][Full Text] [Related]
3. Less invasive surfactant administration via infant feeding tube versus InSurE method in preterm infants: a randomized control trial. Anand R; Nangia S; Kumar G; Mohan MV; Dudeja A Sci Rep; 2022 Dec; 12(1):21955. PubMed ID: 36535971 [TBL] [Abstract][Full Text] [Related]
4. Surfactant administration in preterm babies (28-36 weeks) with respiratory distress syndrome: LISA versus InSurE, an open-label randomized controlled trial. Mishra A; Joshi A; Londhe A; Deshmukh L Pediatr Pulmonol; 2023 Mar; 58(3):738-745. PubMed ID: 36416036 [TBL] [Abstract][Full Text] [Related]
5. Less invasive surfactant administration methods: Who, what and how. Guthrie SO; Roberts KD J Perinatol; 2024 Apr; 44(4):472-477. PubMed ID: 37737494 [TBL] [Abstract][Full Text] [Related]
6. Minimally invasive surfactant therapy with a gastric tube is as effective as the intubation, surfactant, and extubation technique in preterm babies. Aguar M; Cernada M; Brugada M; Gimeno A; Gutierrez A; Vento M Acta Paediatr; 2014 Jun; 103(6):e229-33. PubMed ID: 24628379 [TBL] [Abstract][Full Text] [Related]
7. A systematic review of surfactant delivery via laryngeal mask airway, pharyngeal instillation, and aerosolization: Methods, limitations, and outcomes. Devi U; Roberts KD; Pandita A Pediatr Pulmonol; 2022 Jan; 57(1):9-19. PubMed ID: 34559459 [TBL] [Abstract][Full Text] [Related]
8. Less Invasive Surfactant Administration (LISA) Versus INSURE Method in Preterm Infants: a Retrospective Study. Dini G; Santini MG; Celi F Med Arch; 2024; 78(2):112-116. PubMed ID: 38566872 [TBL] [Abstract][Full Text] [Related]
9. Five-year single center experience on surfactant treatment in preterm infants with respiratory distress syndrome: LISA vs INSURE. Buyuktiryaki M; Alarcon-Martinez T; Simsek GK; Canpolat FE; Tayman C; Oguz SS; Kutman HGK Early Hum Dev; 2019 Aug; 135():32-36. PubMed ID: 31229792 [TBL] [Abstract][Full Text] [Related]
10. Less Invasive Surfactant Administration: A Viewpoint. Mani S; Rawat M Am J Perinatol; 2024 Jan; 41(2):211-227. PubMed ID: 36539205 [TBL] [Abstract][Full Text] [Related]
11. Alternative routes of surfactant application - An update. Kribs A; Roberts KD; Trevisanuto D; O' Donnell C; Dargaville PA Semin Fetal Neonatal Med; 2023 Dec; 28(6):101496. PubMed ID: 38040586 [TBL] [Abstract][Full Text] [Related]
12. Timing of surfactant treatment in respiratory distress syndrome. van Kaam AH; Niemarkt HJ; Onland W Semin Fetal Neonatal Med; 2023 Dec; 28(6):101495. PubMed ID: 38012889 [TBL] [Abstract][Full Text] [Related]
18. Should less invasive surfactant administration (LISA) become routine practice in US neonatal units? Kakkilaya V; Gautham KS Pediatr Res; 2023 Apr; 93(5):1188-1198. PubMed ID: 35986148 [TBL] [Abstract][Full Text] [Related]
19. Experience of less invasive surfactant administration with a 5F infant feeding tube in a tertiary center of low- and middle-income countries. Sk MH; Saha B Pediatr Int; 2023; 65(1):e15668. PubMed ID: 38009628 [TBL] [Abstract][Full Text] [Related]
20. Less Invasive Surfactant Administration (LISA) vs. Intubation Surfactant Extubation (InSurE) in Preterm Infants with Respiratory Distress Syndrome: A Pilot Randomized Controlled Trial. Pareek P; Deshpande S; Suryawanshi P; Sah LK; Chetan C; Maheshwari R; More K J Trop Pediatr; 2021 Aug; 67(4):. PubMed ID: 34595526 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]